Literature DB >> 12171601

Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.

Steven J Compton1, Sabrina Sandhu, Suranga J Wijesuriya, Morley D Hollenberg.   

Abstract

We have analysed the role of N-linked glycosylation in regulating human proteinase-activated receptor-2 (hPAR(2)) expression and function. Epitope-tagged wild-type hPAR(2) (wt-hPAR(2)) or hPAR(2) that lacked glycosylation sequons (following site-directed mutagenesis) in either the N-terminus [hPAR(2)N30A (Asn(30)-->Ala)], extracellular loop 2 [ECL2; hPAR(2)N222Q (Asn(222)-->Gln) or hPAR(2)N222A (Asn(222)-->Ala)] or both (hPAR(2)N30A,N222A or hPAR(2)N30A,N222Q) were expressed in the Chinese-hamster ovary (CHO) fibroblast cell line, Pro5. Western blot analysis of wt-hPAR(2) showed mature wt-hPAR(2) to have a molecular mass of 55-100 kDa, and 33-48 kDa following N -glycosidase F deglycosylation. FACS analysis and immunocytochemistry of the wt-hPAR(2) and PAR(2) mutant cell lines revealed that removal of both glycosylation sequons decreases (50% of wt-hPAR(2)) cell surface expression. Western blot analysis indicated that both N-linked sites are glycosylated. In functional studies, hPAR(2)N30A displayed a selective and significant increase in sensitivity towards tryptase. Interestingly, hPAR(2)N222A displayed a loss in sensitivity towards all PAR(2) agonists tested. However, further analysis revealed receptor sensitivity to alanine mutations in this domain, as the more conservative substitution hPAR(2)N222Q displayed no change in response to PAR(2) agonists. hPAR(2)N30A,N222Q displayed increased sensitivity towards tryptase, but a loss in sensitivity towards trypsin and the synthetic peptide SLIGRL-NH(2), although this loss in sensitivity towards trypsin and SLIGRL-NH(2) was secondary to changes in cell-surface expression. Finally, expression of sialic-acid-deficient wt-hPAR(2) in the CHO Lec2 glycosylation-deficient mutant cell line, showed a 40 kDa loss in molecular mass, in addition to a marked and selective increase in sensitivity towards tryptase. We conclude that hPAR(2) N-linked glycosylation and sialylation regulates receptor expression and/or signalling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171601      PMCID: PMC1222997          DOI: 10.1042/BJ20020706

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

3.  Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.

Authors:  T Takeuchi; J L Harris; W Huang; K W Yan; S R Coughlin; C S Craik
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide.

Authors:  B D Blackhart; L Ruslim-Litrus; C C Lu; V L Alves; W Teng; R M Scarborough; E E Reynolds; D Oksenberg
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

5.  Receptor occupancy and tissue response.

Authors:  M NICKERSON
Journal:  Nature       Date:  1956-09-29       Impact factor: 49.962

6.  Role of asparagine-linked oligosaccharides in the function of the rat PTH/PTHrP receptor.

Authors:  A T Zhou; I Assil; A B Abou-Samra
Journal:  Biochemistry       Date:  2000-05-30       Impact factor: 3.162

7.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 9.  Glycosylation and rheumatic disease.

Authors:  J S Axford
Journal:  Biochim Biophys Acta       Date:  1999-10-08

10.  Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.

Authors:  B Al-Ani; M Saifeddine; A Kawabata; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

View more
  31 in total

Review 1.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Proteases display biased agonism at protease-activated receptors: location matters!

Authors:  Angela Russo; Unice J K Soh; JoAnn Trejo
Journal:  Mol Interv       Date:  2009-04

3.  Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.

Authors:  Fionnuala Ní Ainle; James S O'Donnell; Jennifer A Johnson; Laura Brown; Eimear M Gleeson; Owen P Smith; Roger J S Preston
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

4.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2.

Authors:  Yutaka Kida; Hiroyoshi Inoue; Takashi Shimizu; Koichi Kuwano
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

6.  N-linked glycosylation of protease-activated receptor-1 second extracellular loop: a critical determinant for ligand-induced receptor activation and internalization.

Authors:  Antonio G Soto; JoAnn Trejo
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

7.  A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.

Authors:  Peng Huang; Chongguang Chen; Stephen D Mague; Julie A Blendy; Lee-Yuan Liu-Chen
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

8.  Evaluation of antibodies directed against human protease-activated receptor-2.

Authors:  Mark N Adams; Charles N Pagel; Eleanor J Mackie; John D Hooper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-31       Impact factor: 3.000

9.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.

Authors:  Qing Zhang; Helle H Petersen; Henrik Ostergaard; Wolfram Ruf; Arthur J Olson
Journal:  Proteins       Date:  2009-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.